Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.3 | 2.26 |
NAV | ₹30.52 | ₹283.00 |
Fund Started | 20 Jun 2019 | 01 Aug 2005 |
Fund Size | ₹853.63 Cr | ₹1126.13 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.3
2.26
NAV
₹30.52
₹283.00
Fund Started
20 Jun 2019
01 Aug 2005
Fund Size
₹853.63 Cr
₹1126.13 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year | -0.87% | -1.09% |
3 Year | 21.00% | 24.09% |
5 Year | 13.86% | 15.29% |
1 Year
-0.87%
-1.09%
3 Year
21.00%
24.09%
5 Year
13.86%
15.29%
Equity | 97.67% | 98.75% |
Cash | 2.33% | 1.24% |
Equity
97.67%
98.75%
Cash
2.33%
1.24%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.47% |
Apollo Hospitals Enterprise Ltd. | 7.30% |
Cipla Ltd. | 6.76% |
Lupin Ltd. | 4.79% |
Abbott India Ltd. | 4.56% |
Torrent Pharmaceuticals Ltd. | 4.47% |
JB Chemicals & Pharmaceuticals Ltd. | 4.31% |
Aurobindo Pharma Ltd. | 4.19% |
Fortis Healthcare Ltd. | 4.07% |
Ajanta Pharma Ltd. | 3.88% |
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
Name | Dhaval Joshi | Kamal Gada |
Start Date | 10 Jun 2024 | 02 May 2022 |
Name
Dhaval Joshi
Kamal Gada
Start Date
10 Jun 2024
02 May 2022
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 20 Jun 2019 | 01 Aug 2005 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
20 Jun 2019
01 Aug 2005